Non-invasive biomarkers for monitoring the immunotherapeutic response to cancer

Immunotherapy is an efficient way to cure cancer by modulating the patient’s immune response. However, the immunotherapy response is heterogeneous and varies between individual patients and cancer subtypes, reinforcing the need for early benefit predictors. Evaluating the infiltration of immune cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Nisar, Sabah, Bhat, Ajaz A., Hashem, Sheema, Yadav, Santosh K., Rizwan, Arshi, Singh, Mayank, Bagga, Puneet, Macha, Muzafar A., Frenneaux, Michael P., Reddy, Ravinder, Haris, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727217/
https://www.ncbi.nlm.nih.gov/pubmed/33298096
http://dx.doi.org/10.1186/s12967-020-02656-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727217/
https://www.ncbi.nlm.nih.gov/pubmed/33298096
http://dx.doi.org/10.1186/s12967-020-02656-7

Ejemplares similares